Abstract：OBJECTIVE: To investigate the biological characteristics of childhood T-lineage acute lymphoblastic leukemia (T-ALL) and their clinical significance. METHODS: Immunophenotyping was performed by three-color flow cytometry analysis using CD45 /SSC gating in 23 children with newly diagnosed T-ALL. Meanwhile cytogenetic analysis was performed. RESULTS: CD3+ expression of T-lineage antigens was apparently higher than CD7+ and CD5+ expression. CD19+ expression of B-lineage antigens was apparently higher than CD22+, CD10+ and CD20+ expression. Myeloid antigen was expressed in 4 cases (17%). CD34+ and HLA-DR+ were observed in 4 cases (17%) and 5 cases (22%), respectively. cCD3+ and cCD79+ were expressed in 23 cases (100%) and 22 cases (96%), respectively. The chromosome detection in 8 cases with T-ALL showed hyperdiploid or Ph+ chromosome (one case each). The fusion gene detection in 5 cases showed MLL rearrangements in two cases and positive SIL/TAL1 fusion gene in one case. CD3 expression was related with the complete remission rate. CONCLUSIONS: Immunophenotyping is an important tool for diagnosis of T-ALL. However, the immunophenotype of T-ALL is heterogeneous. So, immunophenotyping along with cytogenetic and molecular genetic analysis is needed in the treatment and prognosis evaluation of T-ALL.［Chin J Contemp Pediatr, 2010, 12 (8):605-608］
［1］Coustan-Smith E, Sandlund JT, Perkins SL, Chen H, Chang M, Abromowitch M, et al. Minimal disseminated disease in childhood T-cell lymphoblastic lymphoma: a report from the children′s oncology group［J］.J Clin Oncol, 2009, 27(21):3533-3539.
［5］Smock KJ, Nelson M, Tripp SR, Sanger WG, Abromowitch M, Cairo MS, et al. Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: a report from the Children's Oncology Group［J］.Pediatr Blood Cancer, 2008, 51(4):489-494.
［9］Abdelhaleem M. The expression of cytoplasmic CD79a correlates with surface CD3 expression in childhood T-ALL lymphoblasts［J］.Leuk Res, 2008, 32(3):511-512.
［10］Cox CV, Martin HM, Kearns PR, Virgo P, Evely RS, Blair A. Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia［J］.Blood, 2007, 109(2):674-682.
［11］Gottardo NG, Hoffmann K, Beesley AH, Freitas JR, Firth MJ, Perera KU, et al. Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia［J］. Br J Haematol, 2007, 137(4):319-328.
［12］Estes DA, Lovato DM, Khawaja HM, Winter SS, Larson RS. Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples［J］.Br J Haematol, 2007, 139(1):20-30.
［13］Sazawal S, Bakhshi S, Raina V, Swaroop C, Saxena R.Detection and clinical relevance of BCR-ABL fusion gene in childhood T-lineage acute lymphoblastic leukemia: a report on 4 cases［J］. J Pediatr Hematol Oncol, 2009, 31(11):850-852.
［14］Mansur MB, Emerenciano M, Splendore A, Brewer L, Hassan R, Pombo-de-Oliveira MS, et al. T-cell lymphoblastic leukemia in early childhood presents NOTCH1 mutations and MLL rearrangements［J］.Leuk Res, 2010, 34(4):483-486.
